4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000903423-16-001320
10% owner bought 66,500 shares at $14.00 ($931,000)
- 10% owner acquired 3,154,127 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GLAXOSMITHKLINE PLC 10% owner | 2016-10-24 | Conversion | +2,942,560 | 2,942,560 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2016-10-24 | Conversion | +211,567 | 3,154,127 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2016-10-24 | Purchase | +66,500 | $14.00 | $931,000 | 3,220,627 | I |
| Derivatives | |||||||
| GLAXOSMITHKLINE PLC 10% owner | 2016-10-24 | Conversion · Series A-3 Preferred Shares | −2,942,560 | 0 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2016-10-24 | Conversion · Series B Preferred Shares | −211,567 | 0 | I | ||
| Open-market purchases · 66,500 sh · avg $14.00 · $931,000 | |||||||
Loading xslF345X03/glaxo-crispr.xml…